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ABSTRACT 
 
ALHABABI, DALAL, ALI., Masters of Science : June : [2019:], Biomedical Sciences  
Title: ANTIMICROBIAL RESISTANCE IN COMMENSAL ESCHERICHIA COLI 
ISOLATED FROM FOOD ANIMALS IN QATAR 
Supervisor of Thesis: Dr. Hadi, Mohamad, Yassine 
 Background: The dissemination of antimicrobial resistance (AMR) bacteria is 
associated with the inappropriate use of antibiotics in both humans and animals. In 
particular, the use of antibiotics for prophylactic and growth promotion purposes in food-
producing animals, in addition to animal-group medication for prolonged times, have 
rendered many of the antibiotics ineffective, returning us to the old times when a simple 
infection could be deadly. Objectives: This study aims at evaluating the incidence of AMR 
in Qatar under the one health approach; i.e., human-animal-environmental interface.  
Specifically, we aim to characterize the phenotypic and genotypic AMR pattern of 18 
clinically relevant antibiotics in major food-producing animals. Ultimately, we aim to 
compare our findings to the data released by the monitoring programs in Hamad Medical 
Corporation (HMC) along with previously published reports from Qatar. Methods: Animal 
fecal samples from camels, cattle, and pigeons (100 samples from each species) were 
collected from slaughterhouses and farms distributed in different locations in Qatar. One 
gram of fecal sample was vigorously homogenized with 3 ml sterile Phosphate Buffered 
Saline (PBS), the suspension was streaked directly onto chromogenic Tryptone Bile X-
glucuronide agar for E. coli detection. Single typical E. coli colonies (blue-green) were 
randomly selected and streaked onto MacConkey agar plates and then recovered on 
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nutrient agar plates for lactose fermentation testing by indole spot. The antibiotic 
susceptibility test was conducted using a Kirby-Bauer disk diffusion assay on Mueller-
Hinton agar plates. Results: A total recovery rate of 88.7% (n=266) achieved from all 
samples. Overall, E. coli isolates had resistance to ten antibiotics in pigeon group, eight 
antibiotics in cattle group and only five antibiotics in camel group. Resistance to at least 
one antibiotic was recorded in 63 E. coli isolates (70.7%) from pigeons, 32 isolates (37.2%) 
from cattle and only in 19 isolates (20.8%) from camels. Multi-drug resistant (MDR) was 
highest in isolates from pigeons reaching 50% (n=44), followed by isolates from cattle 
(7%) and camels (2.2%). Highest resistance rate was observed against tetracycline, 
reaching a frequency of 64%, 27.9% and 15% of isolates from pigeons, cattle and camels, 
respectively (p <0.0001). Moreover, trimethoprim/sulfamethoxazole (an antibiotic used to 
treat a variety of bacterial infections) resistance was present in 22.2% (n=59) of all E. coli 
isolates, with the highest prevalence in pigeons (49.4%), followed by 11.6% in cattle and 
5% in camels. Interestingly, one E. coli isolate from pigeon showed resistance to colistin, 
a drug of last resort in human medicine against gram-negative bacterial infection. 
Conclusions: We previously reported high multi-drug resistance of commensal E. coli in 
chickens, with significant resistance to colistin. We observed lower AMR profile in 
ruminants, presumably due to the different antibiotics used in the two animal industries. 
Nonetheless, the high resistance profile observed in pigeons (70.7%), including high 
multidrug resistance (50%) is alarming, as these animals could rapidly disseminate 
resistant bacteria to various locations. Interestingly, no ESBL producing E. coli reported. 
Nonetheless, continuous monitoring of AMR in livestock animals in Qatar is necessary 
toward introducing antimicrobial stewardship program and control of antibiotics usage in 
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the veterinary sector.  
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I. INTRODUCTION 
The introduction of antibiotics into the medical practice field was one of the major 
achievements contributing to the significant reduction of morbidity and mortality due to 
communicable diseases(Caruso, 2018). Antimicrobial agents include a wide variety of 
pharmaceutical and natural substances that exhibit antimicrobial activity against bacteria, 
protozoa, viruses, and fungi (Leekha, Terrell, & Edson, 2011). This thesis is exclusively 
focused on the antibacterial agent of clinical significance; thus, the term antibiotics will be 
used in this narrower context.  
Antibiotics are either a naturally occurring, semi-synthetic or synthetic substances 
(Demain, 2009). Initially, potential antibiotics are initially tested ‘in vitro’ for their ability 
to inhibit bacterial growth as bacteriostatic or bactericidal  (Murray et al., 2011). Those 
antibiotics that are able to inhibit bacterial growth in vitro, are then tested in vivo as as well 
as clinical trials. There are different mechanisms by which these antibiotics inhibit bacterial 
growth. Mainly, the action of antibiotics is mediated by their interactions with specific 
bacterial target sites leading to inhibition of bacterial cell wall synthesis, protein or other 
metabolites synthesis, as well as nucleic acid replication (Neu, 1992).   
The development of antimicrobial resistance (AMR) phenomena has emerged in 
the post-antibiotic era, in which, different bacterial species showed resistance to the actions 
of different antibiotics as a response to selective antibiotic pressure (Mulvey & Simor, 
2009). Thus, antimicrobial resistance is then defined by the ability of the bacterium to 
survive and grow after exposure to an antibiotic that initially used to inhibit or kill such 
bacterial population, under the effect of selective pressure (Fair & Tor, 2014).  
  
   
2 
 
As a matter of fact, the extensive and uncontrolled use of antibiotic is the main 
factor that selects for the development of resistant strains which later may become 
predominant (Mulvey & Simor, 2009). Therefore, antimicrobial resistance is a 
multifactorial phenomenon that compromised the antibiotic drug efficacy, in which 
bacteria have developed mechanisms to overcome the action of the antibiotics via different 
resistance mechanisms (Demain, 2009).  
The bacteria could be intrinsically resistant to the antibiotic, or they can acquire the 
resistance by different means due to the bacterial genome flexibility (D'Costa, McGrann, 
Hughes, & Wright, 2006). Mainly, the intrinsic resistance is mediated by the inheritance 
of chromosomal genes. Virtually, all gram-negative bacilli have intrinsic resistance to 
vancomycin (Murray et al., 2011). On the other hand, resistance could be acquired either 
due to a mutation in the bacterial chromosomal DNA or by acquiring new resistance genes 
that present on transferable DNA segments including plasmids, integrons as well as 
transposons (Shehabi, Odeh, & Fayyad, 2006; Summers, 2002). 
Together, resistance mediated genes encode proteins or ribosomal RNA that enable 
bacteria to have biochemical mechanisms to evade the actions of antibiotics. For instance, 
resistance determinants including the production of enzymes that hydrolyze the drug, 
alterations in the target site structure, and limit the access of adequate concentration of 
antibiotics via decrease the permeability or increase the expression of efflux pumps in the 
bacterial outer membrane (Neu, 1992). 
The emergence of antimicrobial resistant bacteria has been considered globally as 
a growing public health threat in the 21st century. Clinically, the standard therapies for 
infections caused by antibiotic-resistant strains become less efficient leading to mortality 
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and burden financial cost (WHO, 2015). The AMR problem has been exaggerated 
considering the limited releasing of new antibiotics in the market (Freire-Moran et al., 
2011). 
Globally, the estimated mortality due to AMR infections reaches 700,000 deaths 
annually (O’neill, 2016). It is expected that by the year 2050, the figure is amplified as 
more than 10 million deaths per year will be attributed to AMR infections among human 
worldwide (O’neill, 2016). The emergence and dissemination of AMR bacteria are majorly 
associated with the inappropriate use of antibiotics in both human healthcare and veterinary 
sector (Anthony D. So, 2016). In particular, there is a growing evidence that the non-
judicious use of antibiotics in animal agriculture majorly contributes to the development of 
antimicrobial resistance in animal-associated bacteria (Molbak, 2004). Moreover, there are 
accumulating reports from different regions around the globe about the emergence of 
multidrug-resistant bacteria in different livestock species. Subsequently, food animals are 
also shown to be responsible for accelerating the spread of AMR bacteria to humans and 
environment  (Caruso, 2018); (Threlfall, Ward, Frost, & Willshaw, 2000). 
In food animals, although the antibiotics are prescribed clinically to control 
infections, the crisis of antibiotic resistance is driven by inappropriate use. The group 
medication of animals for prolonged times and in low dosages, mostly through the feed for 
nontherapeutic purposes, have been demonstrated to be the main risk factors for the 
development of resistance (WHO, 2017b). Since the 1950s, antimicrobial growth 
promotants (AGPs) were promoted for the use in subtherapeutic concentrations. Examples 
of these antibiotics includes penicillin and tetracycline that are used in animals’ food to 
increase the weight ratio for poultry, cattle as well as swine (Pagel & Gautier, 2012). 
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Interstingly, it has then been reported that the intestinal commensal bacteria of both animals 
and workers in farms using those growth promoters have a high antimicrobial resistance to 
common antibiotics (Aarestrup, Wegener, & Collignon, 2008). Moreover, antibiotics have 
been prescribed for animals for either metaphylaxis and prophylaxis purposes.  
Metaphylaxis is a control treatment for the group of animals to prevent the occurrence of 
the highly probable outbreak when part of the group is diagnosed with an infection (FDA, 
2012; Pagel & Gautier, 2012). On the other hand, prophylaxis is a preventive treatment to 
prevent the occurrence of an infection (FDA, 2012; WHO, 2017b). More importantnly, it 
has been demonstrated  that the chronic and continues administration of a single antibiotic 
would leat to development of resistance to other antibiotics through different mechanisms, 
noting that resistance genes could be carried on plamids and/or transposon (Marshall & 
Levy, 2011).  
Of high importance, it is estimated that 75% to 90% of antibiotics consumed by 
food animals are not metabolized; therefore excreted largely into the surrounding 
environment (Marshall & Levy, 2011). Consequently, the activities of the excreted 
antibiotics are showed to be retained in the environment for considerable time (Manyi-Loh, 
Mamphweli, Meyer, & Okoh, 2018). Hence, the propagation of active antibiotics and 
metabolites represents another route of transmission from farms to the environment, where 
environment becomes a reservoir of circulating resistance genes in the community (Manyi-
Loh et al., 2018). As a matter of fact, studies reported AMR bacteria in farm dust 
(Hamscher, Pawelzick, Sczesny, Nau, & Hartung, 2003), the groundwater within farms 
locations (Dolliver, Kumar, & Gupta, 2007), and the food crops where antibiotic-
containing manure is used (Brooks & McLaughlin, 2009). The environmental organisms 
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that are exposed to the discharge of unmetabolized antibiotics will be effectively promoted 
to undergo selection with resistance mutations and thereafter exchange such genes among 
various bacterial species (Aarestrup et al., 2008).  
In particular, the antimicrobial classes that ranked by World Health Organization 
(WHO) as highly important for human medicine (WHO, 2017a), become commonly 
administrated in livestock agriculture and production (OIE, 2017). Recent sales data 
released in 2015 by the Food and Drug Administration (FDA) reported that almost 10 
million kilograms of medically important antibiotics were sold for food animals in the 
United States (FDA, 2016). Furthermore, in France only, 60% of total antibiotics 
consumption is recorded in the veterinary section (Moulin et al., 2008). As a consequence, 
there are direct and indirect pieces of evidence supporting the potential role posed by 
antimicrobial resistant bacteria from animal sources on human health (Marshall & Levy, 
2011).  Recent reports from WHO have further emphasized the burden food-borne and 
animal-origin antimicrobial resistant bacteria on animal health (Scott et al., 2018; WHO, 
2017b).  
Commensal bacteria including Enterobacteriaceae are common enteric flora in 
mammals and are frequently studied for AMR purposes (van den Bogaard & Stobberingh, 
2000). Experimentally, antimicrobial resistance genes have been reported to transmit 
horizontally between commensal and zoonotic members of the Enterobacteriaceae 
including both Escherichia coli and Salmonella species, respectively (Poppe et al., 2005). 
Moreover, E. coli can acquire and maintain resistance genes, and serve as a reservoir of 
resistant genes for zoonotic bacteria (Poppe et al., 2005). From the public health viewpoint, 
E. coli is a representative marker for the selection pressure created by antibiotic use, and is 
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the predictor for future development of  antibiotic resistance in others pathogens in various 
environment (Caruso, 2018). 
Considering all the above, the AMR is currently investigated and looked at under 
the “One Health” approach, which  represents the interlink between three domains: human, 
animals, and environment. Principally, the One Health approach is defined as the 
multidisciplinary efforts/collaborations to achieve the optimal health of people through 
tackling the problem at animals and environment levels, in addition to humans (Robinson 
et al., 2016). In this regard, the contribution of antibiotics use in livestock production to 
the global AMR crises is determined by the ability of AMR genetic determinants to 
subsequently transmit to human pathogens as well as other commensal microbiota. This 
could happen either directly through contacts of animals,  or indirectly through contact with 
contaminated environment or consumption of contaminated food (Chang, Wang, Regev-
Yochay, Lipsitch, & Hanage, 2015). 
As an action, countries such as United States, Canada, and Australia, have decided 
to limit the use of clinically-relevant antibiotics in food animals, supported by active 
surveillance and continuous monitoring of AMR (Singer, Shaw, Rhodes, & Hart, 2016). In 
Netherland, the government has regulated the use of antibiotics in food animals reaching a 
50% reduction in usage in 2013 as compared to 2009 and a 70% decrease in 2015. AMR 
continues monitoring surveillance concluded significant reduction in AMR pattern within 
a period of six years (Havelaar et al., 2017). Officially, the FDA supported the conclusion 
that the nontherapeutic use of medically important antibiotics in food animal production 
contributes to a potential health risk for public health (FDA, 2016). A recommendation 
document was released in 2010 to ultimately limit the use of these drugs in animals (FDA, 
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2012). 
In contrast, this is not the situation in Qatar, where only scanty short-term studies 
emerged to assess the level of AMR in the veterinary sector. Clinically, antimicrobial 
stewardship program (AMSP) has been implemented in Qatar general hospitals since 
March 2015 (Ribero Pombo MH & Thompson D, 2018).  Accordingly, the appropriate use 
of antibiotic has been improved by promoting the selection of the optimal antibiotic 
regimen including dosing, duration of therapy, and route of administration (Pawluk, Black, 
& El-Awaisi, 2015). 
AMSP program is structured to monitor antibiotic use and reduce the antimicrobial 
resistance at the hospital level through enforcement of the antibiotic restriction policy in 
Qatar (Pawluk et al., 2015). For instance, the effect of the implementation of an 
antimicrobial stewardship program in Hamad Medical Corporation was clear in the 
prevalence of MDR Pseudomonas Aeruginosa that declined from 8.1% in 2015 to 4.9% in 
2017 (HMC, antibiogram report,2017). 
Nevertheless, there is a lack of AMR surveillance data in bacteria isolated from 
food-producing animals to understand AMR pattern in the veterinary sector. On 2016, 
WHO; International Health Regulations (IHR); released a mission report evaluating the 
health security system in Qatar with recommendations to urgently prioritize the 
development of integrated AMR surveillance including animal sector under the one health 
approach (WHO, 2017c). Therefore, there is an urgent need to develop an AMR monitoring 
program in the veterinary sector as a step to develop and implement the antimicrobial 
stewardship (AMS) in agriculture (WHO, 2017c).  
Recently, antibiotic-resistant bacteria has been studied in food-producing animals 
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including broiler chickens (N. O. Eltai et al., 2018) and sheep (unpublished data) as 
baseline studies in Qatar. Both studies estimated the AMR level using commensal E. coli 
as an indicator. Data from chicken revealed a high prevalence of antimicrobial resistance 
in commensal E. coli, includind MDR, with 90% of E. coli isolates being resistant to at 
least one antibiotic. Moreover, the study reported colistin resistance in about 15% of E. 
coli isolates, all being encoded by plasmid-mediated colistin resistance gene (mcr-1). That 
was the first report of its kind in the MENA region. Detection of colistin resistance is a 
worrying finding as colistin is the last resort antibiotic prescribed for MDR gram-negative 
bacterial infections. This is more worrying  considering its mobility on plasmids (Liu et 
al., 2016). Furthermore, 2.2% of the isolates were extended-spectrum β-lactamase (ESBL) 
producers (N. O. Eltai et al., 2018). In another unpublished data from the same research 
group, commensal E. coli isolates from healthy sheep also had a high prevalence of 
resistance (90%), with MDR isolates frequency reaching 44% (Personal communication; 
Dr. Nahla Eltai). One of the significant findings on AMR pattern in sheep study is the high 
prevalence of resistance to critically important antibiotic ciprofloxacin, which is a member 
of fluoroquinolones class that has been banned on 2005 in the united states to be used in 
livestock agriculture (OIE, 2017). 
Considering the recently previous studies on both broiler chickens and sheep in 
Qatar, such alarming findings necessities a broader assessment of AMR in the animal 
sector locally. Accordingly, we initiated this study to evaluate AMR it two main food-
producing animals (cattle and camels) as well as pigeons, which could be a vector for 
transporting resistant bacteria across long distances.  
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AIM: 
Considering the recent findings in chicken, the lack of AMR studies in veterinary 
sector in Qatar, and the need to immediate comply with the antimicrobial stewardship 
(AMS) under the “one health approach, the aim of this study is to provide baseline 
information on the incidence of antimicrobial resistance (AMR) in several food-producing 
animals in Qatar. 
OBJECTIVES: 
The overall objective of this study is to characterize the phenotypic and genotypic 
AMR pattern of 18 clinically relevant antibiotics in commensal E. coli isolated from fecal 
samples of camels, cattle, and pigeons collected from slaughterhouses and farms in Qatar. 
Our ultimate goal is to compare our findings to the data released by the monitoring 
programs in Hamad Medical Corporation (HMC) along with previously published reports 
from Qatar and to provide evidence-based recommendations to guide and improve 
stewardship programs in clinical and veterinary medicine.  
 
 
 
 
 
 
 
 
  
   
10 
 
II. LITERATURE REVIEW 
GENERAL ASPECTS OF ANTIMICROBIAL RESISTANCE: 
Antibiotics are a group of synthetic, semisynthetic, or naturally occurring agents 
with bacteriostatic or bactericidal properties (WHO, 2017a). The introduction of antibiotics 
in human medicine was one of the greatest medical achievement in the 20th century to 
reduce morbidity and mortality associated with infectious diseases (Fair & Tor, 2014). 
Afterward, antibiotics have been introduced to food animal agriculture for different 
purposes including treatment, prevention, and growth promotion (Pagel & Gautier, 2012). 
Nonetheless, the excessive and uncontrolled use of antibiotics in both human and 
veterinary medicine contributed to the development of resistant pathogens where simple 
bacterial infections become hard to be treated (Fair & Tor, 2014; WHO, 2015). Precisely, 
the antibiotic resistance has been defined as the ability of the bacterium to grow and survive 
in the presence of the antibiotic agent that previously showed an antibacterial effect via the 
acquisition of different antibiotic resistance mechanisms (Fair & Tor, 2014).  
There are major antibiotic resistance mechanisms including production of enzymes 
that inactivate the antibiotic agent; modification in the antibiotic target site; reduction of 
bacterial cell wall permeability; and increasing export of antibiotics via active pumps 
(Tenover, 2006). Further, studies showed that resistance genes could be exchanged from 
resistant, to susceptible bacteria through conjugation, transformation, or transduction in 
environmental settings (Tenover, 2006). 
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PUBLIC HEALTH IMPACTS OF ANTIMICROBIAL USE IN FOOD ANIMAL 
PRODUCTION: 
The antimicrobial use in food animals has been shown to have a negative impact 
on human health (WHO, 2015). In particular, resistant animal-associated commensals have 
been shown to directly impacts the health of people in close contact with farm animals, and 
indirectly to a wider population via the food chain (Marshall & Levy, 2011). Of great 
concern, antibiotic-resistant commensals from animal sources can colonize humans and 
transfer their resistance genes to human-associated commensals as well as to human 
foodborne pathogens including Salmonella and Campylobacter (Barlow et al., 2015; 
WHO, 2017b).  
Studies suggested that antibiotic-resistant bacteria and resistance genes can enter 
into the community settings via environmental spread from farms, slaughterhouses as well 
as occupational workers and their families (Marshall & Levy, 2011). Katsunuma et al. 
reported a significantly high prevalence of AMR in commensal bacteria among poultry, 
pigs and cattle farm workers around Japan, suggesting occupational exposure risk factor 
for spreading AMR (Katsunuma et al., 2007). In another study, Aubry-Damon et al. 
compared the AMR profile of commensal enterobacteria between farmers and non-farmers 
who reported no recent exposure to antibiotics. Results showed a significantly higher 
prevalence of AMR resistance in farmers against cotrimoxazole, tetracycline, 
streptomycin, and nalidixic acid compared to non-farmers (Aubry-Damon et al., 2004). 
Another supportive study reported that risk the for having multidrug-resistant E. coli was 
32 times higher in farm workers compared with community referents (Price et al., 2007). 
Bertrand et al. documented chronologically the transfer of extended-spectrum beta-
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lactamase (ESBL) gene (CTX-M-2) in Salmonella enterica from poultry species in farms 
to poultry meat products, and then to humans in the same region in Belgium (Bertrand et 
al., 2006). 
On the other hand, supplementary studies reported the direct link between reducing 
the antimicrobial use in food animals and the decrease in resistance to those antimicrobials 
in these animals. A randomized controlled trial (RCT) by Kaneene et al. studied the impact 
of continues feeding of dairy calves with oxytetracycline and neomycin antibiotics in milk 
versus a discontinuing feeding group. Results showed that discontinuation of antimicrobial 
consumption leads to an increase in susceptibility to tetracyclines in both E. coli and 
Salmonella species in treated animals (Kaneene et al., 2008). 
COMMENSAL E. COLI AS AN INDICATOR FOR AMR SURVEILLANCE: 
Commensal bacteria are considered to be the reservoir of AMR genes that could be 
transferred to zoonotic pathogenic bacteria (Tenover, 2006). Therefore, AMR level in 
commensal bacteria can be measured as a good indicator to predict the prevalence of AMR 
in other pathogens within a particular environment. In particular, commensal intestinal 
Escherichia coli (E. coli) strains are considered as good reliable indicators for antimicrobial 
resistance surveillance in both human and animals (Szmolka & Nagy, 2013; van den 
Bogaard, Willems, London, Top, & Stobberingh, 2002). E. coli is characterized to have 
genetic flexibility to adapt to environmental changes; thus, it easily acquires different 
resistance mechanisms during the lifetime of their host (Szmolka, Anjum, La Ragione, 
Kaszanyitzky, & Nagy, 2012). Importantly, E. coli could be isolated and recovered with 
cost-effective laboratory standards (van den Bogaard et al. 2000). 
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AMR IN COMMENSAL E. COLI FROM LIVESTOCK: 
Here, we focus only on selected major livestock species, especially cattle, camels; 
and poultry including pigeons, which considered globally as food-producing animals. 
AMR IN COMMENSAL E. COLI FROM CATTLE: 
AMR bacteria have been investigated and characterized widely in cattle species. A 
recent study reported a high prevalence of resistance to streptomycin (47.5%), tetracycline 
(45.4%), and ampicillin (34.2%) in commensal E. coli isolated from  different dairy cattle 
farms in Jordan (Obaidat, Bani Salman, Davis, & Roess, 2018). The same study showed 
that 83.7% of herdsmen purchased antibiotics without a veterinary prescription. Further, 
antibiotics use and their doses were frequently changed if no treatment response was 
recorded (Obaidat et al., 2018). Likewise, Pereira et al. studied the phenotypic antibiotic 
resistance of 1,423 E. coli isolates from rectal swabs of dairy calves, from eight farms in 
New York. They reported significant phenotypic resistance to both ciprofloxacin and 
ceftriaxone, where fluoroquinolones and third-generation cephalosporins were used in food 
animals (Pereira et al., 2014). Moreover, a cross-sectional study of 1,736 fecal samples 
from pre-weaned calves and cows cattle on 38 farms in California, Oregon, and 
Washington showed that 55% of E. coli isolates were resistant to tetracycline, 28% to 
ampicillin and 31% were multi-drug resistant (Berge, Hancock, Sischo, & Besser, 2010). 
In another study, Bosman et al. investigated the resistance of commensal E. coli isolated 
from white veal calves and reported highest phenotypical resistance against amoxicillin-
tetracycline (31.7%), followed by tetracycline only (23·2%) and amoxicillin-tetracycline-
ciprofloxacin-TMP/SMX (10·5%) (Bosman, Wagenaar, Stegeman, Vernooij, & Mevius, 
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2014). On the other side of the world, researchers from South Korea reported that around 
94% of E. coli isolates from beef cattle fecal samples were phenotypically resistant to 
tetracycline, associated with presence of tetracycline resistance genes including tet(A) 
(46.5%), tet(B) (45.1%) and tet(C) (5.8%).  These data suggested the exchange of genetic 
materials encoding for resistance in the studied population (Shin, Shin, Jung, Belaynehe, 
& Yoo, 2015). Interestingly, Duse et al. reported that antimicrobials treatments of cows 
during lactation resulted in significantly more antibiotic resistant E. coli strains in the feces 
of pre-weaned dairy calves. In this particular study, they reported the resistance of E. coli 
to streptomycin (90%), nalidixic acid (49%), or cefotaxime (11%) (Duse et al., 2015). The 
authors concluded that minimizing the feeding of milk from cows treated with 
antimicrobials during lactation should lower the prevalence of resistant E. coli in the 
gastrointestinal tract of the calves. 
In contrast, a study performed on fecal samples from beef cattle, dairy cattle and 
veal calf from slaughterhouses in Australia revealed a low level of resistant E. coli to 
antibiotics of low importance in human medicine (Barlow et al., 2015). This finding 
positively reflected the strict governmental regulations of antimicrobials usage in food 
animals in Australia (Barlow et al., 2015; Pagel & Gautier, 2012).  
AMR IN E. COLI FROM CAMELS: 
Few studies have been published on AMR incidence in camel’s species. A recent 
study from Nigeria showed that multidrug-resistant Shiga toxin-producing E. coli (STEC) 
isolated from the fecal samples is higher in cattle compared to camels (Adamu et al., 2018). 
In another study from Tunisia, E. coli strains isolated from diarrheic and healthy camel 
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fecal samples showed a high frequency of resistance to tetracycline (52.8%), and ampicillin 
(37.1%) (Bessalah et al., 2016). In another study from southern Tunisia demonstrated the 
absence of plasmid-mediated mobilized colistin resistance genes (mcr-1 and mcr-2) in E. 
coli isolated from camel feces (Rhouma et al., 2018).  In an interesting study from 
Kingdom of Saudi Arabia (KSA), Fadlelmula et al. compared AMR level in commensal E. 
coli isolated from camels with those of pathogenic E. coli isolated from human urinary 
tract infections (UTIs) (Fadlelmula, Al-Hamam, & Al-Dughaym, 2016). Molecular testing 
revealed the presence of ESBL producer E. coli strains in 26.9 % of camel samples and 
36.4 % of human samples, suggesting that camels could be a potential reservoir for AMR 
E. coli strains in Saudi Arabian community (Fadlelmula et al., 2016). 
AMR IN COMMENSAL E. COLI FROM PIGEONS: 
Similar to camels, few studies reported the antimicrobial resistance profile in 
pigeons. In a low-income setting in Nicaragua, Hasan et al. reported the existence of ESBL-
producing E. coli in about 13% poultry pigeons compared to 8% in other domestic and 
wild birds, and 27% in healthy humans (Hasan et al., 2016). Interestingly,  another study 
from South Africa addressed the risk of AMR E. coli spread due to pigeon fecal samples 
contamination of the roof-harvested rainwater (Chidamba & Korsten, 2015). In particular, 
they reported resistance to ampicillin (22.7.9%), gentamicin (23.6%), amikacin (24%), 
tetracycline (17.4) and amoxicillin (16.9%) (Chidamba & Korsten, 2015). In another study 
from Iran that evaluated AMR of commensal E. coli isolated from fecal samples from 
pigeons, high resistance to tetracycline (88·4%) and doxycycline (74·4%) was reported 
(Askari Badouei, Zahraei Salehi, Koochakzadeh, Kalantari, & Tabatabaei, 2014). In 
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Bangladesh, Hasan et al. examined resistance profile of E. coli from household pigeon 
fecal samples and showed that 89% of E. coli isolates were resistant to one or more 
critically important human antibiotics including ampicillin, ciprofloxacin, gentamicin, and 
tigecycline, with low ESBLs prevalence (Hasan et al., 2014). Another study from Poland 
investigated AMR profile of three bacterial species isolated from pigeons: E. coli, 
Salmonella typhimurium, and beta-hemolytic coagulase-positive staphylococci.  It was 
found that E. coli isolates had higher resistance against Amoxicillin (63%), Oxytetracycline 
(75%) and Sulfamethoxazole/trimethoprim (53%) as compared to Staphylococci and 
Salmonella typhimurium (Stenzel et al., 2014).  
EFFECTS OF CONTROL USE OF ANTIBIOTICS IN FOOD ANIMALS: 
Unlike the situation in humans, control of antibiotics use in animals has not been 
strictly implemented in many nations. In the few countries that regulate the use of 
antimicrobials in agriculture, studies have shown a reduction in the prevalence of resistant 
bacteria. In a six-year period (2009-2015) of antibiotic control use in Netherlands for 
example, a significant reduction of resistant bacteria, reaching 70% in some cases, was 
reported in multiple animals including chickens, pigs, calves and cows (Havelaar et al., 
2017). A similar observation was published in Australia cattle herds (Barlow et al., 2015). 
In Belgium, governmental restrictions for antimicrobial consumption in the veterinary 
section during the period between 2010 and 2013 also resulted in a reduction of resistance 
in commensal E. coli strains from veal calves, young beef cattle, broiler chickens and 
slaughter pigs against 11 antibiotics (Hanon et al., 2015). Interestingly, the overall 
prevalence of resistance and multi-resistance was the lowest in the beef cattle livestock 
category compared to other animal groups (Hanon et al., 2015). 
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III. MATERIALS AND METHODS 
SAMPLING SITES AND SAMPLES COLLECTION:  
Animal fecal samples from pigeons, dairy cattle and camels (100 samples from 
each species) were collected from slaughterhouses and farms distributed in different 
locations in Qatar. Sampling process was performed during the period between end of 
December 2018 to February 2019 by two qualified veterinarians in collaboration with the 
Ministry of Public Health (MOPH). Samples were subsequently transported to Qatar 
University; Biomedical Research Center; Microbiology Laboratory for immediate 
processing. 
E. COLI ISOLATION AND IDENTIFICATION: 
Research approval to process samples were obtained from Qatar University's 
Institutional Biohazard Committee under approval number  QU (QU-IBC-2018/034). One 
gram of fecal sample was vigorously homogenized with 3 ml sterile Phosphate Buffered 
Saline (PBS). The suspended samples were streaked using sterile cotton swab onto 
chromogenic Tryptone Bile X-glucuronide agar (TBX; HiMedia Laboratories, India) for 
E. coli detection and incubated at 37oC for 18-24 hours. Subsequently, single typical E. 
coli colonies (blue-green colonies) were selected randomly and streaked onto MacConkey 
agar plates (HiMedia Laboratories, India) then incubated at 37⸰C for 18-24 hours to 
differentiate lactose fermenter isolates. Next, pink colonies from MacConkey agar were 
randomly selected to recovered on nutrient agar plates (HiMedia Laboratories, India) to 
obtain pure single colonies. Lactose fermenter isolates were further tested by indole spot 
test (Thermo Fisher Scientific, KS). For further confirmation, biochemical reactions tested 
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by Crystal ™ Enteric/ nonfermenter id KIT, BD via Biomic V3 software (Giles scientific, 
USA). E. coli isolates were then directly tested for antibiotic susceptibility testing. Pure E. 
coli isolates were preserved in cryovial tubes (Technical Service Consultant, UK) and 
stored at -80⸰C until further testing.  
ANTIBIOTIC SUSCEPTIBILITY TESTING OF E. COLI ISOLATES:  
The antibiotic susceptibility test was conducted using a Kirby-Bauer disk diffusion 
assay on Mueller-Hinton agar plates (Medysinal FZCO, Dubai). E. coli isolates were 
recovered on nutrient agar, and single colonies were suspended in 0.85% saline (Medysinal 
FZCO, Dubai) to achieve an inoculum equivalent to 0.5 McFarland standard as measured 
by DensiCHEK Plus (bioMerieux, France). The suspension was streaked along the surface 
of Mueller-Hinton agar plates. Antibiotic-impregnated discs (Liofilchem, Italy) were 
applied to the inoculated plate surface with sterile forceps, and plates were incubated at 
36±1oC for 18 to 24 hours. Maximum of six antibiotic discs were placed on a 100-mm plate 
using the antibiotic disc dispenser. The diameter of the inhibition zone around each disc 
was measured in millimeters and interpreted according to the Clinical and Laboratory 
Standards Institute (CLSI) criteria(CLSI, 2018). As the E. coli QC isolate ATCC 25922 is 
reported in CLSI to show a susceptibility to colistin disc diffusion in a range from 11 to17 
mm, therefore in our study, we considered any E. coli isolate with growth inhibition 
diameter  ≤ 10 mm to be resistant to colistin. For subsequent confirmation, colistin-resistant 
E. coli isolates were tested for colistin resistance using susceptibility test strips (E-test strip, 
Liofilchem, Italy) on Mueller-Hinton agar plates. The zone of inhibition was examined, 
and the Minimum Inhibitory Concentrations (MICs) were determined. Alternatively; as no 
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CLSI interpretive breakpoints have been established to interrupt colistin resistance results; 
the European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints 
(EUCAST, 2019)  were used. Thus, we included any E. coli isolate with MIC of ≤2 µg/mL 
according to EUCAST interpretive criteria. E. coli ATCC 25922 was used as a control 
strain in all steps. The eighteen clinically relevant antibiotics used to screen the antibiotic 
susceptibility of E. coli are listed in Table 1.  
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Table 1: List of antibiotics tested, their concentrations and zone diameter interpretive 
results for E. coli 
 
Antimicrobial Agent Code Disk content 
(µg) 
Zone diameter breakpoints 
and CLSI interpretive criteria  
S I R 
PENICILLINS  
Ampicillin AMP 10 ≥ 17 14–16 ≤ 13 
β-LACTAM COMBINATION AGENTS  
Amoxicillin-clavulanic 
acid 
AUG 30 ≥ 18 14–17 ≤ 13 
Piperacillin-tazobactam TZP 110 ≥ 21 18–20 ≤ 17 
CEPHEMS  
Cephalothin KF 30 ≥ 15 __ ≤ 14 
Cefuroxime CXM  30 ≥ 18 15–17 ≤ 14 
Ceftriaxone  CRO 30 ≥ 23 20–22 ≤ 19 
Cefepime  FEP  30 ≥ 25 19–24 ≤ 18 
CARBAPENEMS  
Ertapenem  ETP 10 ≥ 22 19–21 ≤ 18 
Meropenem  MRP 10 ≥ 23 20–22 ≤ 19 
LIPOPEPTIDES  
Colistin Sulfate CS 30 ≥ 11 - ≤ 10 
AMINOGLYCOSIDES  
Amikacin  AK 30 ≥ 17 15–16 ≤ 14 
Gentamicin  GN 10 ≥ 15 13–14 ≤ 12 
TETRACYCLINES  
Tetracycline  TE 30 ≥ 15 12–14 ≤ 11 
QUINOLONES AND FLUOROQUINOLONES  
Ciprofloxacin  CIP 5 ≥ 21 16–20 ≤ 15 
FOLATE PATHWAY ANTAGONISTS 
Trimethoprim-
sulfamethoxazole  
SXT 25 ≥ 16 11–15 ≤ 10 
PHENICOLS  
Chloramphenicol  C 30 ≥ 18 13–17 ≤ 12 
FOSFOMYCINS  
Fosfomycin  FOS 200 ≥ 16 13–15 ≤ 12 
NITROFURANS  
Nitrofurantoin  F 300 ≥ 17 15–16 ≤ 14 
S, sensitive; I, intermediate; R, resistant 
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DNA EXTRACTION AND MULTIPLEX PCR DETECTION: 
For any phenotypically confirmed colistin resistant, E. coli isolate, further 
molecular testing was performed to detect the presence of plasmid-mediated colistin 
resistance mcr genes. DNA was extracted using QIAamp UCP Pathogen Mini Kit (Qiagen, 
Germany) following the provided manufacturer’s instructions from overnight nutrient agar 
culture. Extracted DNA was subjected to a multiplex PCR protocol as recently described 
(Rebelo et al., 2018). The primers used in this protocol as summarized in Table 2; targeting 
mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 genes in all Enterobacteriaceae. The PCR was 
performed in a total volume of 25 µl containing 12.5 µL 1x Master Mix (New England 
Biolabs, UK), 3.5 µl of nuclease-free water, 0.5µl of each forward and reverse primers 
designed for each single gene, and 2µl of DNA template. The reaction mixture was 
amplified using GeneAmp PCR System 9700 Thermocycler under the following 
conditions: 1 cycle of denaturation at 94°C for 15 min, followed by 25 cycles of 
denaturation at 94°C for 30 s, annealing at 58°C for 90 s and elongation at 72°C for 60 s, 
and a final cycle of elongation at 72°C for 10 min. The amplified products were visualized 
by electrophoresis using 1.2% agarose gel (Agarose LE, Paisley, UK), stained with 
ethidium bromide (Promega, WI) using iBright™ CL1000 Imaging System (Invitrogen, 
Thermo Fisher Scientific, KS). The DNA marker used was 1Kbp plus ladder (Invitrogen, 
Thermo Fisher Scientific, KS). E. coli isolate run in parallel with one positive control 
“colistin resistant” and one negative control “E. coli ATCC 25922”. 
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Table 2: Primers used for multiplex PCR panel to detect plasma-mediated colistin 
resistance genes (mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5) 
Name Sequences 
Expected 
band size 
(bp) 
mcr1_320bp_fw AGTCCGTTTGTTCTTGTGGC 320bp 
mcr1_320bp_rv AGATCCTTGGTCTCGGCTTG 
Mcr2_700bp_fw CAAGTGTGTTGGTCGCAGTT 715bp 
Mcr2_700bp_rev TCTAGCCCGACAAGCATACC 
mcr3_900bp_fw AAATAAAAATTGTTCCGCTTATG 929bp 
mcr3_900bp_rev AATGGAGATCCCCGTTTTT 
mcr4_1100bp_fw TCACTTTCATCACTGCGTTG 1,116bp 
mcr4_1100bp_rev TTGGTCCATGACTACCAATG 
MCR5_fw ATGCGGTTGTCTGCATTTATC 1,644bp 
MCR5_rev TCATTGTGGTTGTCCTTTTCTG 
 
 
STATISTICAL ANALYSIS: 
Data were entered into Microsoft Excel 2016 spreadsheet (Microsoft Corporation, 
New York, USA) for initial analysis. Data were reviewed, and values were color-coded as 
green “sensitive”; yellow “intermediate”; and red “resistant.” Graphs were plotted, and 
statistical analysis was performed with GraphPad Prism v8.0.2. The resistance percentage 
was calculated for each antibiotic in each animal group separately by dividing the total 
number of resistant isolates on the total number of tested isolates. An E. coli isolate was 
considered as multi-drug resistant if it was resistant to at least three antibiotic classes as 
previously defined (Hanon et al., 2015). Correlations among resistances to a particular 
antibiotic across the three animal groups and in each animal group across three localities 
were done using Chi-square test. A p-value ≤0.05 on a two-sided level was considered to 
be statistically significant. In this study, isolates with intermediate susceptibility to the 
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tested antibiotics were considered as susceptible for analysis.  
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IV. RESULTS 
 A total of 266 (88.7%) E. coli isolates were recovered, were each isolate 
represented one fecal sample (Table 3). We found no significant difference in the recovery 
rate from the three animal categories (p=0.5325). The frequency of antimicrobial resistance 
of those isolates for 18 clinically relevant antibiotics is shown in Figure1. Overall, E. coli 
isolates had resistance to ten antibiotics in pigeon group, eight antibiotics in dairy cattle 
and only five antibiotics in camel group. The distribution of the number of E. coli isolates 
per livestock category with the corresponding prevalence of isolates resistant to at least one 
antibiotic are shown in Table 3 and figure1.  About 71% (n=63 of 89) of pigeon E. coli 
isolates were resistant to at least one antibiotic. On the other hand, 36.5% (n=31 of 86) and 
20.8% (n=19) of E. coli isolates from dairy cattle group and camels, respectively, were 
resistant to at least one antibiotic.  
  
 
Table 3: Number of collected samples and E. coli isolates recovered, for each animal group 
and the corresponding percentages of isolates resistant to at least one antibiotic 
 
Characteristics Animal groups Total P value 
Pigeons Cattle Camels 
Number of collected 
samples 
100 100 100 300 ----- 
Number of recovered 
E. coli isolates 
89 86 91 266 0.5325 
Recovery rate (%) 89 86 91 88.7 ----- 
Resistance to at least 
one antibiotic % 
63 
(70.7%) 
31 
(36.5%) 
19 
(20.8%) 
114 (42.8%) <0.0001 
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Figure 1. Number of resistant E. coli isolates to at least one antibiotic across the animal 
groups. **** indicates P value is statistically significant by Fisher’s exact test (<0.0001); while ns for 
non-significance. 
 
 
 As shown in Figure 2, The prevalence of resistance varied according to the type of 
antibiotics across the three animal categories examined. Resistance to tetracycline was the 
most common, observed in 64, 27.9 and 15% of isolates from pigeons, cattle and camels, 
respectively. Similarly, resistance to ampicillin was also observed across the three animal 
groups with a prevalence rate of 55.1, 14 and 7% in isolates from pigeons, cattle and 
camels, respectively. Moreover, trimethoprim/sulfamethoxazole resistance was present in 
59 (22.2%) of all E. coli isolates, with higher prevalence in 49.4% pigeons, followed by 
11.6% and 5% prevalence in cattle and camels, respectively. Similar resistance was 
observed for chloramphenicol which was detected in 15.7, 7 and 2% of isolates from 
pigeons, cattle and camels, respectively. Susceptibility (resistance was absent among E. 
coli from any animal group) for nine antibiotics were observed in all livestock categories 
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for the following antibiotics: amoxicillin-clavulanic acid, piperacillin-tazobactam, second, 
third and fourth generation cephalosporins including cefuroxime, ceftriaxone, cefepime 
along with fosfomycin, amikacin and carbapenems ertapenem, and meropenem. Resistance 
to cephalothin was observed in pigeons (11.2%) and only one isolate from camels (1%). 
Resistance to gentamicin, and ciprofloxacin was observed in pigeon and cattle isolates. The 
resistance of E. coli isolates to nitrofurantoin was recorded only in pigeons (4.5%).  
 
 
Am
pi
cil
lin
Ce
ph
al
ot
hi
n
G
en
ta
m
ici
n
SX
T
Co
lis
tin
Ni
tro
fu
ra
nt
oi
n
Ch
lo
ra
m
ph
en
ico
l
Ci
pr
of
lo
xa
cin
Te
tra
cy
cli
ne
0
20
40
60
Antibiotics
N
o.
 o
fE
.c
ol
i i
so
la
te
s
Pigeons
Cattle
Camels
✱✱✱✱
✱✱✱
✱
✱✱✱✱
ns ✱
✱✱
✱
✱✱✱✱
 
Figure 2. Antibiotic resistance profile for resistant E. coli isolates (n=266) to different 
antibiotics per animal category. TZP: piperacillin/tazobactam; SXT: Trimethoprim/ sulfamethoxazole. 
**** indicates that P value is statistically significant by Fisher’s exact test (<0.0001); while ns for 
non-significance. 
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 One E. coli isolate from pigeon showed resistance to colistin. Antibiotic resistance 
for colistin was confirmed phenotypically using E-test strips (Figure 3; B). Furthermore, 
plasmid-mediated colistin resistance was confirmed using multiplex PCR for the detection 
for mcr genes (mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5), where the presence of mcr-1 gene 
was recorded (Figure 4). 
 
 
 
 
 
 
 
 
 
 
Figure 3. Phenotypic antibiotic susceptibility tests used in this study: (A)disc diffusion, (B) 
E-test. (A) In the disk-diffusion assay, the diameter of the growth inhibition zone is measured in mm around 
the antibiotic disc. (B) In antibiotic susceptibility test strips (E-test strip), zone of inhibition is examined to 
determine the minimal inhibitory concentration (MICs). 
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Figure 4. The mcr-1 gene detection in colistin-resistant E. coli isolated from pigeon; lane1, 
susceptible E. coli isolate; lane 2, E. coli isolate from pigeon; lane 3, positive control E. coli isolate. Lane 4, 
negative control corresponds to E. coli isolate (ATCC 25922). M, molecular size marker and the size of 
each amplicon is indicated at the side; bp, base pairs. 
 
 
 Phenotypic resistance pattern, including multidrug resistance, varied considerably 
among different isolates from the three animal groups. The antibiotic resistance pattern 
observed in isolates from pigeons was generally different from that of cattle and camels. 
Distribution of multidrug resistance in pigeon isolates is recorded in figure 5. Only 4.49% 
(n=4) of the isolates were resistant to a maximum of six antibiotics in pigeon group (figure 
5), 8.99% (n=8) were resistant to five antibiotics, 12.4% (n=11) were resistant to four 
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antibiotics, 24.7% (n=22) were resistant to three antibiotics, 5.62% (n=5) were resistant to 
two antibiotics, and 14.6% (n=13) were resistant to one antibiotic.   
 
 
 
Figure 5. Frequency bar chart for the distribution of phenotypic antibiotic resistance among 
E. coli isolates from different animal groups 
 
 
 In pigeons, fifty percent (n=44) of the isolates were Multi-drug resistant (MDR), 
with distribution pattern summarized in Table 4. The highest multidrug resistance was 
recorded to ampicillin; trimethoprim/sulfamethoxazole; tetracycline in 20.2 % (n=18) of 
the isolates. Other multidrug resistance patterns were recorded between 1.1% for a 
1 2 3 4 5 6
0
5
10
15
20
25
No. of antibiotics
N
o
. 
o
f 
re
s
is
ta
n
t
E
. 
c
o
li 
is
o
la
te
s
Pigeons
Cattle
Camels
  
   
30 
 
combination of ampicillin; cephalothin; ciprofloxacin, and up to 6.7 % for a combination 
of ampicillin; trimethoprim/sulfamethoxazole; chloramphenicol; tetracycline.  
 
 
Table 4: Phenotypic resistance profile of E. coli isolates from pigeons fecal samples (n=89) 
Resistant phenotype Frequency Percentage 
No resistance 26 29.2 
Resistant to only one antibiotic 13 14.6 
Ampicillin, Tetracycline 4 4.5 
Ampicillin, Trimethoprim/sulfamethoxazole 1 1.1 
Trimethoprim/sulfamethoxazole, Tetracycline 1 1.1 
Ampicillin, Cephalothin, Ciprofloxacin 1 1.1 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Tetracycline 
19 21.3 
Gentamicin, Trimethoprim/sulfamethoxazole, 
Tetracycline 
1 1.1 
Ampicillin, Cephalothin, Tetracycline 2 2.2 
Ampicillin, Gentamicin, 
Trimethoprim/sulfamethoxazole, Tetracycline 
2 2.2 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Ciprofloxacin, Tetracycline 
2 2.2 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Chloramphenicol, Tetracycline 
6 6.7 
Ampicillin, Cephalothin, Gentamicin, 
Ciprofloxacin, Tetracycline 
1 1.1 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Chloramphenicol, Ciprofloxacin, Tetracycline 
2 2.2 
Ampicillin, Cephalothin, 
Trimethoprim/sulfamethoxazole, Chloramphenicol, 
Tetracycline 
2 2.2 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Nitrofurantoin, Chloramphenicol, Tetracycline 
1 1.1 
Ampicillin, Gentamicin, 
Trimethoprim/sulfamethoxazole, Nitrofurantoin, 
Tetracycline 
1 1.1 
Ampicillin, Cephalothin, 
Trimethoprim/sulfamethoxazole, Nitrofurantoin, 
Chloramphenicol, Tetracycline 
2 2.2 
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Ampicillin, Cephalothin, Gentamicin, 
Trimethoprim/sulfamethoxazole, Ciprofloxacin, 
Tetracycline 
1 1.1 
Ampicillin, Gentamicin, 
Trimethoprim/sulfamethoxazole, Chloramphenicol, 
Ciprofloxacin, Tetracycline 
1 1.1 
 
 
 In dairy cattle group, only 1.2% (n=1) of the isolates were resistant to a maximum 
of five antibiotics, 2.3% (n=2) were resistant to four and three antibiotics, 11.6% (n=10) 
were resistant to two antibiotics, and 17.4% (n=15) were resistant to only one antibiotic. 
Around 7% (n=6) of isolates from cattle group were Multi-drug resistant (MDR), with 
distribution pattern summarized in Table 5. All observed multidrug resistance patterns 
were recorded in a low frequency of 1.2% (n=1) for different antibiotic combinations.  
 
 
Table 5: Phenotypic resistance profile of E. coli isolates from cattle fecal samples (n=86) 
Resistant phenotype Frequency Percentage 
No resistance 55 64 
Resistant to only one antibiotic 15 17.4 
Ampicillin, Tetracycline 1 1.2 
Ampicillin, Trimethoprim/sulfamethoxazole 4 4.7 
Trimethoprim/sulfamethoxazole, Tetracycline 3 3.5 
Chloramphenicol, Tetracycline 2 2.3 
Ampicillin, Ciprofloxacin, Tetracycline 1 1.2 
Chloramphenicol, Ciprofloxacin, Tetracycline 1 1.2 
Gentamicin, Trimethoprim/sulfamethoxazole, 
Chloramphenicol, Tetracycline 
1 1.2 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Ciprofloxacin, Tetracycline 
1 1.2 
Ampicillin, Gentamicin, Chloramphenicol, 
Ciprofloxacin, Tetracycline 
1 1.2 
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Ampicillin, Trimethoprim/sulfamethoxazole, 
Chloramphenicol, Ciprofloxacin, Tetracycline 
1 1.2 
 
 
 On the other hand, the phenotypic antibiotic resistance profile in isolates from 
camels had a different pattern as illustrated in Figure 5. Only 2.2% (n=2) were resistant to 
three antibiotics, 7.7% (n=7) were resistant to two antibiotics, and 10.9% (n=10) were 
resistant to only one antibiotic. Antibiotic resistance to four, five and six antibiotics were 
not observed in camel isolates.  As illustrated in Table 6, only two isolates (2.2%) showed 
multidrug resistance patterns for a combination of ampicillin; chloramphenicol; 
tetracycline, and a combination of ampicillin; trimethoprim/sulfamethoxazole; 
tetracycline. 
 
 
Table 6: Phenotypic resistance profile of E. coli isolates from camels fecal samples (n=91) 
Resistant phenotype Frequency Percentage 
No resistance 72 79.1 
Resistant to only one antibiotic 10 11.0 
Trimethoprim/sulfamethoxazole, Tetracycline 4 4.4 
Ampicillin, Tetracycline 1 1.1 
Ampicillin, Cephalothin 1 1.1 
Chloramphenicol, Tetracycline 1 1.1 
Ampicillin, Chloramphenicol, Tetracycline 1 1.1 
Ampicillin, Trimethoprim/sulfamethoxazole, 
Tetracycline 
1 1.1 
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 The frequency of resistance to different antibiotics in different localities for pigeons 
and cattle groups were cross-tabulated using Chi-square test. In pigeon group, as shown in 
Figure 6, only frequency in resistance to ampicillin, trimethoprim/sulfamethoxazole, and 
tetracycline was significantly different among the three localities (p<0.0001, <0.0001 and 
0.0004, respectively).  
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Figure 6. Phenotypic profile of antibiotic resistance E. coli isolates from pigeons across 
three localities. 
 
 
 In dairy cattle group, a significant difference in resistance was reported only against 
ampicillin and trimethoprim/sulfamethoxazole, with p values (0.036,0.009; respectively) 
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(Figure 7). Comparison between different localities for AMR resistance in E. coli isolates 
from camels have not been studied as all fecal samples obtained from the central 
slaughterhouse in Qatar.  
 
 
  
Figure 7. Phenotypic profile of antibiotic resistance E. coli isolates from Cattle across three 
localities. 
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V. DISCUSSION 
 The main idea of the “One Health” approach is that the health of humans and 
animals are closely linked and form one unity in a particular environment. Accordingly, 
knowledge of the AMR patterns in bacteria present in food-producing animals is essential 
to estimate the potential health risk on humans. In Qatar, many efforts have been pursued 
to control the antibiotics clinical use by implementing the antimicrobial stewardship 
program (AMSP) in general hospitals since April 2015 (Ribero Pombo MH & Thompson 
D, 2018).  However, there is minimal control of antibiotics use in the veterinary sector. 
Further, there is a lack of data about the prevalence of antibiotic-resistant bacteria in food-
producing animals. To fill this gap, we have recently started a surveillance study to estimate 
the prevalence of antibiotic-resistant bacteria in food-producing animals using commensal 
E. coli from fecal samples as an indicator. Globally, E. coli strains have become a common 
component of all AMR surveillance programs for their ability to acquire antimicrobial 
resistance genes and subsequently transfer them horizontally to other bacteria (Szmolka & 
Nagy, 2013).  
 In a recent study, we demonstrated a high level of antibiotics resistance of E. coli 
isolates from broiler chicken, including multidrug and colistin resistance (Nahla O. Eltai et 
al., 2018). This high level of resistance was associated with a low recovery rate of 
commensal E. coli from fecal samples (52%; 90/172).  Using the same methodology, we 
achieved higher overall commensal E. coli recovery rate reaching 88.7% (266/300) from 
the three animal groups in this study: Cattle, camels, and pigeons.  
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 In the chicken study, the overall resistance rate in commensal E. coli reached 90% 
for at least one antibiotic, with significant resistance to colistin (15.5%). In contrast, we 
observed a lower AMR profile in all livestock groups (70.7% in pigeons, 37.2% in cattle, 
and 20.8% in camels), presumably due to the different antibiotics use in different animal 
species industries.  
 Nonetheless, the high phenotypic AMR profile observed in pigeons for at least one 
antibiotic (70.7%) is a major finding. Further, we reported a remarkably high percentage 
(50%) of MDR, which is in agreement with the former study in broiler chickens (Nahla O. 
Eltai et al., 2018). MDR pattern in pigeons reached up to six antibiotic classes, mostly for 
a combination of ampicillin, trimethoprim/sulfamethoxazole, and tetracycline (20.2%). In 
part, the phenotypic AMR pattern in pigeons for the most prevalent antibiotics was similar 
to that reported in chickens; that is illustrated by high resistance to ampicillin (72.2%), 
trimethoprim-sulfamethoxazole (63.3%), and cephalothin (15.5%). Cumulatively, these 
findings suggest high use of the former three antibiotics in the poultry industry in Qatar. 
Unfortunately, we could not obtain information about the antibiotic practice in the three 
farms were pigeon samples were collected. Nonetheless, the high multidrug resistance of 
pigeon E. coli isolates is alarming as such birds can rapidly disseminate and spread the 
antibiotic-resistant bacteria species to various locations, affecting other animals and human 
health. 
 Furthermore, this study is the second report for colistin resistance in poultry birds 
in Qatar, where colistin is considered a drug of last resort in human medicine to treat 
infections with gram-negative bacteria. Although only one E. coli isolate from pigeon was 
found to have colistin resistance, such resistance could rapidly spread to other 
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environments considering it is plasmid mediated. Using PCR, we confirmed that this 
resistance was encoded by mcr-1 gene. Similarly, all colistin resistance in chicken were 
also mcr-1 encoded and were detected in about 15.5% (n=14) of E. coli isolates. It is worth 
noting that mcr-1 gene is the only gene reported in Qatar out of a total of eight genes 
reported globally.  The prevalence of colistin resistance in the poultry industry, in 
particular, suggest the use of colistin as a prophylaxis agent in Qatar poultry industry. 
Interestingly, colistin resistance encoded by mcr-1 gene in addition to 15 other antibiotic 
resistance genes were detected in a virulent clone of E. coli strain (MS8345), serotype 
O2:K1:H4,  in Qatar (Forde et al., 2018). 
 On the other hand, the fecal samples collected from cattle were solely obtained from 
dairy cattle, where enough information about antibiotic usage was available, and thus, the 
correlation between antibiotic exposure and resistance development can be concluded. 
Considering the routine use of oxytetracycline and amoxicillin for treatment and control of 
multiple diseases, resistance frequency to tetracycline (27.9%) and ampicillin (14%) was 
expected. However, although gentamicin has also been reported to be used in the three 
cattle farms, the resistance against this antibiotic was only recorded in seven isolates 
(2.3%). 
 Interestingly, the lowest AMR frequency was observed in E .coli isolated from 
camel samples. Only 19 (20.8%) isolates from camels showed resistance to at least one 
antibiotic,  with overall resistance pattern recorded for only five antibiotics. Highest 
resistance was reported to tetracycline (15%) and ampicillin (7%). In contrast, a similar 
study from Tunisia higher frequency of resistance to tetracycline and ampicillin in E. coli 
isolates from camels, reaching 52.8% and 37.1% (Bessalah et al., 2016). Moreover, a study 
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from KSA reported that 26.9% of E. coli isolates from camel fecal samples are ESBL 
producer (Fadlelmula et al., 2016). In agreement with our findings, another research group 
from Tunisia reported the absence of colistin resistance genes mcr-1 and mcr-2 in E. coli 
isolated from camel fecal samples in southern Tunisia territory (Rhouma et al., 2018).  
Considering that Qatar is a relatively small county, we did not expect major changes in 
AMR profile between different localities. Expectedly, out of 18 clinically-relevant 
antibiotics used in this study, only the frequency of resistance to ampicillin and 
trimethoprim/sulfamethoxazole was significantly different among the three localities in 
pigeons (<0.0001, <0.0001; respectively) and cattle groups (0.036,0.009; respectively). 
Further, the resistance profile to tetracycline was also significantly different in pigeon 
samples collected from the three farms (0.0004). Although minor, the differences of AMR 
patterns between different localities reflects different antibiotic practices, and therefore, 
impose the need to assess and educate the herdsmen, veterinarians and farms owners about 
the judicious use of antibiotics in animals.  
 In contrast, all camel samples were collected from the central slaughterhouse in 
Qatar and hence, we could not compare the resistance profiles among different localities. 
On the other hand, having samples collected from the central slaughterhouse suggests 
different origins of these samples. Nonetheless, low AMR level observed.  
 This study revealed an overall low resistance pattern of E. coli isolates from large 
food animals. The E. coli isolates that did exhibit AMR for the panel we tested (18 
clinically relevant antibiotics) are most likely resistant to the older set of antibiotics such 
as tetracycline, ampicillin, and trimethoprim-sulfamethoxazole (antibiotic used to treat a 
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variety of bacterial infections). The susceptibility of E. coli isolates to all tested antibiotics, 
regardless of the animal origin, reached 57.5% (153/266). Additionally, the absence of 
resistance to critical and highly important antibiotics including second, third and fourth 
generation, carbapenems, fosfomycin and no ESBL producing E. coli was reported. These 
data suggest that control of antibiotics use in large food animals could be easily achieved, 
and hence, will help in reducing the burden of this globally important issue. On the other 
hand, control of antibiotics use in the poultry industry could be more difficult and requires 
prompt actions.   
 This study provides a snapshot and benchmark assessment of AMR patterns in 
livestock animals in Qatar using commensal E. coli as an indicator. A further larger 
spatiotemporal analysis, including a higher number of farms, is needed. This study majorly 
focused on phenotypic profiling of AMR. Further characterization at the molecular level, 
including full genome/plasmid sequencing, is required. Such studies are now more 
important considering the rapid growth of livestock population in Qatar to overcome the 
blockade and reach self-sustenance. This should be also be paralleled with studying 
resistance pattern along the food chain, including farm workers and food handlers. Most 
importantly, this shall be accompanied with introducing antimicrobial stewardship 
program to control and monitor antibiotics usage.  
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